Causality between insulin use and malignant tumors of the digestive system: a two-sample mendelian randomized study

Abstract Background Existing cohort studies show no association between insulin use and cancers of the digestive system, while numerous meta-analyses suggest that insulin use increases the risk of digestive system tumours. This study uses two-sample Mendelian randomization (MR) to further investigat...

Full description

Saved in:
Bibliographic Details
Main Authors: DengZhuo Chen, YongLi Ma, JingHui Li, Liang Wen, GuoSheng Zhang, ChengZhi Huang, XueQing Yao
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-025-13452-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544505448202240
author DengZhuo Chen
YongLi Ma
JingHui Li
Liang Wen
GuoSheng Zhang
ChengZhi Huang
XueQing Yao
author_facet DengZhuo Chen
YongLi Ma
JingHui Li
Liang Wen
GuoSheng Zhang
ChengZhi Huang
XueQing Yao
author_sort DengZhuo Chen
collection DOAJ
description Abstract Background Existing cohort studies show no association between insulin use and cancers of the digestive system, while numerous meta-analyses suggest that insulin use increases the risk of digestive system tumours. This study uses two-sample Mendelian randomization (MR) to further investigate the causal relationship between the two. Methods We selected single nucleotide polymorphisms (SNPs) strongly associated with insulin use as instrumental variables and used aggregated statistics on digestive system neoplasms as the outcome event. The primary method of analysis was inverse variance weighting (IVW), supplemented by weighted median, MR-Egger regression, weighted mode and simple mode methods. The reliability of the study was assessed by heterogeneity testing, pleiotropy analysis and sensitivity analysis. Result A total of 8 SNPs associated with insulin use were included as instrumental variables. Random-effects IVW analysis showed an association between insulin use and increased risk of colorectal cancer (OR = 1.1037, 95%CI = 1.0183–1.1962, P = 0.016). No statistically significant association was found between insulin use and the development of other digestive system tumours. The results were unaffected by pleiotropy and heterogeneity, and the reliability of the findings was confirmed by sensitivity analysis. Conclusion Our Mendelian randomization study suggests an association between insulin use and an increased risk of CRC, with no clear association observed for other digestive system tumours. However, further MR studies with larger sample sizes from genome-wide association study (GWAS) data are needed to verify this association.
format Article
id doaj-art-47b8da162a524b46a260bc9e68aabac2
institution Kabale University
issn 1471-2407
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj-art-47b8da162a524b46a260bc9e68aabac22025-01-12T12:27:14ZengBMCBMC Cancer1471-24072025-01-0125111110.1186/s12885-025-13452-1Causality between insulin use and malignant tumors of the digestive system: a two-sample mendelian randomized studyDengZhuo Chen0YongLi Ma1JingHui Li2Liang Wen3GuoSheng Zhang4ChengZhi Huang5XueQing Yao6Gannan Medical UniversityGanzhou Hospital of Guangdong Provincial People’s Hospital, Ganzhou Municipal HospitalGannan Medical UniversityGannan Medical UniversityGanzhou Hospital of Guangdong Provincial People’s Hospital, Ganzhou Municipal HospitalDepartment of Gastrointestinal Surgery, Department of General Surgery, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical UniversityGannan Medical UniversityAbstract Background Existing cohort studies show no association between insulin use and cancers of the digestive system, while numerous meta-analyses suggest that insulin use increases the risk of digestive system tumours. This study uses two-sample Mendelian randomization (MR) to further investigate the causal relationship between the two. Methods We selected single nucleotide polymorphisms (SNPs) strongly associated with insulin use as instrumental variables and used aggregated statistics on digestive system neoplasms as the outcome event. The primary method of analysis was inverse variance weighting (IVW), supplemented by weighted median, MR-Egger regression, weighted mode and simple mode methods. The reliability of the study was assessed by heterogeneity testing, pleiotropy analysis and sensitivity analysis. Result A total of 8 SNPs associated with insulin use were included as instrumental variables. Random-effects IVW analysis showed an association between insulin use and increased risk of colorectal cancer (OR = 1.1037, 95%CI = 1.0183–1.1962, P = 0.016). No statistically significant association was found between insulin use and the development of other digestive system tumours. The results were unaffected by pleiotropy and heterogeneity, and the reliability of the findings was confirmed by sensitivity analysis. Conclusion Our Mendelian randomization study suggests an association between insulin use and an increased risk of CRC, with no clear association observed for other digestive system tumours. However, further MR studies with larger sample sizes from genome-wide association study (GWAS) data are needed to verify this association.https://doi.org/10.1186/s12885-025-13452-1Digestive system tumoursInsulin useMendelian randomization
spellingShingle DengZhuo Chen
YongLi Ma
JingHui Li
Liang Wen
GuoSheng Zhang
ChengZhi Huang
XueQing Yao
Causality between insulin use and malignant tumors of the digestive system: a two-sample mendelian randomized study
BMC Cancer
Digestive system tumours
Insulin use
Mendelian randomization
title Causality between insulin use and malignant tumors of the digestive system: a two-sample mendelian randomized study
title_full Causality between insulin use and malignant tumors of the digestive system: a two-sample mendelian randomized study
title_fullStr Causality between insulin use and malignant tumors of the digestive system: a two-sample mendelian randomized study
title_full_unstemmed Causality between insulin use and malignant tumors of the digestive system: a two-sample mendelian randomized study
title_short Causality between insulin use and malignant tumors of the digestive system: a two-sample mendelian randomized study
title_sort causality between insulin use and malignant tumors of the digestive system a two sample mendelian randomized study
topic Digestive system tumours
Insulin use
Mendelian randomization
url https://doi.org/10.1186/s12885-025-13452-1
work_keys_str_mv AT dengzhuochen causalitybetweeninsulinuseandmalignanttumorsofthedigestivesystematwosamplemendelianrandomizedstudy
AT yonglima causalitybetweeninsulinuseandmalignanttumorsofthedigestivesystematwosamplemendelianrandomizedstudy
AT jinghuili causalitybetweeninsulinuseandmalignanttumorsofthedigestivesystematwosamplemendelianrandomizedstudy
AT liangwen causalitybetweeninsulinuseandmalignanttumorsofthedigestivesystematwosamplemendelianrandomizedstudy
AT guoshengzhang causalitybetweeninsulinuseandmalignanttumorsofthedigestivesystematwosamplemendelianrandomizedstudy
AT chengzhihuang causalitybetweeninsulinuseandmalignanttumorsofthedigestivesystematwosamplemendelianrandomizedstudy
AT xueqingyao causalitybetweeninsulinuseandmalignanttumorsofthedigestivesystematwosamplemendelianrandomizedstudy